ArticleArchives of pharmacal research2022

Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling.

Noha F Abdelkader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.